ilmscore | Pharma Sector (Generic Revlimid Impact) Predictions
Pha

Pharma Sector (Generic Revlimid Impact)

Topic
N/A
Accuracy

Recent Predictions

Total: 1
Correct: 0
Incorrect: 0
Pending: 1
Prediction
Author
Predicted at
Status
Video
Companies with high exposure to generic Revlimid (e.g., Natco Pharma, Dr. Reddy's) are predicted to face significant earnings deterioration upon its generic revision expiry in January 2026.
"you can basically understand the impact companies will Will face once generic revision comes off fro..."
Groww Groww
Apr 24, 2025
Pending
Sensex, Nifty rally ...